Compare LATA & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LATA | SRZN |
|---|---|---|
| Founded | 2025 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 229.1M | 213.0M |
| IPO Year | 2025 | N/A |
| Metric | LATA | SRZN |
|---|---|---|
| Price | $10.08 | $24.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $32.00 |
| AVG Volume (30 Days) | 56.6K | ★ 155.5K |
| Earning Date | 01-01-0001 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,604,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.92 | $5.90 |
| 52 Week High | $10.20 | $25.85 |
| Indicator | LATA | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 58.96 | 60.50 |
| Support Level | $10.02 | $21.07 |
| Resistance Level | $10.13 | $25.85 |
| Average True Range (ATR) | 0.01 | 2.33 |
| MACD | 0.01 | 0.26 |
| Stochastic Oscillator | 73.68 | 78.45 |
Galata Acquisition Corp II is a blank check company.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).